FRONTLINE HIGH-DOSE THERAPY (HDT) WITH AUTOLOGOUS STEM-CELL SUPPORT (ASCT) IN YOUNG PTS WITH DISSEMINATED INTERMEDIATE OR HIGH-GRADE LYMPHOMAS - EVALUATION OF FEASIBILITY AND EFFICACY IN CONSECUTIVE PROSPECTIVE TRIALS

Citation
N. Milpied et al., FRONTLINE HIGH-DOSE THERAPY (HDT) WITH AUTOLOGOUS STEM-CELL SUPPORT (ASCT) IN YOUNG PTS WITH DISSEMINATED INTERMEDIATE OR HIGH-GRADE LYMPHOMAS - EVALUATION OF FEASIBILITY AND EFFICACY IN CONSECUTIVE PROSPECTIVE TRIALS, British Journal of Haematology, 102(1), 1998, pp. 237-237
Citations number
NO
Categorie Soggetti
Hematology
ISSN journal
00071048
Volume
102
Issue
1
Year of publication
1998
Supplement
S
Pages
237 - 237
Database
ISI
SICI code
0007-1048(1998)102:1<237:FHT(WA>2.0.ZU;2-U